- Home
- CSAI vs IPHA Comparison
CSAI vs IPHA Comparison
Compare CSAI & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAI
- IPHA
- Stock Information
- Founded
- CSAI N/A
- IPHA 1999
- Country
- CSAI
- IPHA France
- Employees
- CSAI N/A
- IPHA N/A
- Industry
- CSAI
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- CSAI
- IPHA Health Care
- Exchange
- CSAI NYSE
- IPHA Nasdaq
- Market Cap
- CSAI N/A
- IPHA 160.1M
- IPO Year
- CSAI N/A
- IPHA 2019
- Fundamental
- Price
- CSAI $4.14
- IPHA $2.38
- Analyst Decision
- CSAI
- IPHA Strong Buy
- Analyst Count
- CSAI 0
- IPHA 1
- Target Price
- CSAI N/A
- IPHA $11.00
- AVG Volume (30 Days)
- CSAI N/A
- IPHA 31.8K
- Earning Date
- CSAI N/A
- IPHA 03-27-2025
- Dividend Yield
- CSAI N/A
- IPHA N/A
- EPS Growth
- CSAI N/A
- IPHA N/A
- EPS
- CSAI N/A
- IPHA N/A
- Revenue
- CSAI N/A
- IPHA $20,831,349.00
- Revenue This Year
- CSAI N/A
- IPHA $209.83
- Revenue Next Year
- CSAI N/A
- IPHA $83.96
- P/E Ratio
- CSAI N/A
- IPHA N/A
- Revenue Growth
- CSAI N/A
- IPHA N/A
- 52 Week Low
- CSAI N/A
- IPHA $1.29
- 52 Week High
- CSAI N/A
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- CSAI N/A
- IPHA 71.42
- Support Level
- CSAI N/A
- IPHA $2.13
- Resistance Level
- CSAI N/A
- IPHA $2.34
- Average True Range (ATR)
- CSAI 0.00
- IPHA 0.14
- MACD
- CSAI 0.00
- IPHA 0.04
- Stochastic Oscillator
- CSAI 0.00
- IPHA 90.07
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.